Country - United States
Summary - Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive)
Deadline - Dec 19, 2025
MT reference number - 120484265
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 120484265
Document Type - Tender Notices
Description - Description: Amendment 2: Changes to the ISO The purpose of this amendment is to amend the THRIVE ISO. An updated version of the ISO and an updated version of the ISO with tracked changes are included as attachments. Changes to the ISO include: Cost share is now strongly encouraged instead of mandatory. Multi-party teaming arrangements are no longer required. ARPA-H's involvement with regulatory facilitation has been clarified. Please review the amended ISO for all changes. ---------------------------------------------------------------------------------------------------------------- Amendment 1: Added the Frequently Asked Questions (FAQ) to the list of attachments. ------------------------
Mt Ref Id - 120484265
Deadline - Dec 19, 2025
Similar Tenders :
Healthcare and Medicine